Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$27,000.00

Solving the genetics of neuromuscular disorders using multi-omic sequencing

EF 2024-25

Résumé
Neuromuscular disorders (NMDs) are rare but debilitating conditions that affect muscles and the nerves that control them. Many of these disorders are genetic, however diagnosing them is often challenging. Current genetic tests like whole exome sequencing (WES) and short-read whole genome sequencing (WGS) leave many patients without answers because they cannot detect all types of genetic mutations. As a result, only 60% of individuals with NMDs obtain diagnosis.Our research addresses this gap by using advanced technologies to uncover hidden genetic causes of NMDs. We will analyze DNA and RNA from 22 individuals who have NMDs that remain undiagnosed after traditional testing. Using long-read sequencing, a cutting-edge approach that captures much larger pieces of DNA, we can detect complex genetic mutations that previous methods have missed. Additionally, by studying RNA from muscle tissue, we can pinpoint functional changes in the way genes are expressed. As long-read sequencing identifies many variations across an individual genes, a bioinformatics tool will be created to filter that information down to find the variant(s) causing the individual condition. This pipeline will combine long-read sequencing data with clinical characteristics, RNA data and computer tools.The proposed multi-omics approach has the potential to provide a diagnosis for up to 35% more patients in our study. A diagnosis can bring immense benefits: connecting families with support, informing treatment decisions, and guiding future pregnancies with accurate risk information. Further, this study could pave the way for more effective diagnostic tools in the future by advocating for the important role of multi-omics technologies in analyzing complex genetics.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530220
Name
Hamlin Marissa C
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Solving the genetics of neuromuscular disorders using multi-omic sequencing
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatic Filtering; Genetic Disease; Genome Sequencing; Molecular Diagnostics; Multi-Omics; Neuromuscular Disorder; Personalized Treatment; Rare Disease; Transcriptomics; Variant Interpretation
Abstract
Neuromuscular disorders (NMDs) are rare but debilitating conditions that affect muscles and the nerves that control them. Many of these disorders are genetic, however diagnosing them is often challenging. Current genetic tests like whole exome sequencing (WES) and short-read whole genome sequencing (WGS) leave many patients without answers because they cannot detect all types of genetic mutations. As a result, only 60% of individuals with NMDs obtain diagnosis.Our research addresses this gap by using advanced technologies to uncover hidden genetic causes of NMDs. We will analyze DNA and RNA from 22 individuals who have NMDs that remain undiagnosed after traditional testing. Using long-read sequencing, a cutting-edge approach that captures much larger pieces of DNA, we can detect complex genetic mutations that previous methods have missed. Additionally, by studying RNA from muscle tissue, we can pinpoint functional changes in the way genes are expressed. As long-read sequencing identifies many variations across an individual genes, a bioinformatics tool will be created to filter that information down to find the variant(s) causing the individual condition. This pipeline will combine long-read sequencing data with clinical characteristics, RNA data and computer tools.The proposed multi-omics approach has the potential to provide a diagnosis for up to 35% more patients in our study. A diagnosis can bring immense benefits: connecting families with support, informing treatment decisions, and guiding future pregnancies with accurate risk information. Further, this study could pave the way for more effective diagnostic tools in the future by advocating for the important role of multi-omics technologies in analyzing complex genetics.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hamlin, Marissa C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~